Products and Services

9 Months Ended

Sep. 30, 2013

Products and Services [Abstract]

Products and Services

(13) Products and Services

Our broad offering of products is divided into three product categories:

· Catheter products, principally consisting of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions, such as the Pronto extraction catheters used in treating acute myocardial infarction and the GuideLiner^® catheter used to access discrete regions of the coronary anatomy, and also including products used in connection with gaining percutaneous access to the vasculature to perform minimally invasive procedures, such as micro-introducer kits;

· Hemostat products, principally consisting of blood clotting products, such as the D-Stat^® Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets, and the Vasc Band, a compression device to assist hemostasis following a catheterization or other puncture into a blood vessel in a patient’s arm; and

· Vein products and services, principally consisting of the Vari-Lase^® endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, and a reprocessing service for radiofrequency vein ablation catheters.

The following tables set forth, for the periods indicated, net revenue by product category along with the percent change from the previous period:

	Three Months Ended September 30,
	2013					2012
	Net Revenue		Percent Change			Net Revenue		Percent Change
Catheter products	$	17,965,000		17	%	$	15,301,000		15	%
Hemostat products		5,962,000		7	%		5,567,000		(3	%)
Vein products and services		3,999,000		11	%		3,597,000		46	%
Total product revenue		27,926,000		14	%		24,465,000		14	%
License		83,000		(5	%)		87,000		(97	%)
Total revenue	$	28,009,000		14	%	$	24,552,000		1	%

	Nine Months Ended September 30,
	2013					2012
	Net Revenue		Percent Change			Net Revenue		Percent Change
Catheter products	$	52,031,000		14	%	$	45,621,000		16	%
Hemostat products		17,768,000		3	%		17,236,000		(2	%)
Vein products and services		11,398,000		14	%		9,964,000		29	%
Total product revenue		81,197,000		12	%		72,821,000		13	%
License		230,000		(12	%)		262,000		(92	%)
Total revenue	$	81,427,000		11	%	$	73,083,000		8	%